AUM $5.7MER 0.47%NAV $37.82Holdings 69Inception Aug 2022
Price Chart
Key Statistics
Previous Close
$37.77Day Range
$37.72$37.82
52-Week Range
$22.95$40.29
Avg Volume
3.7KDividend Yield
1.00%Expense Ratio
0.47%AUM
$5.7MShares Outstanding
154.8KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 73.09% |
| Ireland | 5.19% |
| Canada | 5.09% |
| Netherlands | 3.79% |
| South Korea | 2.30% |
| Sweden | 2.11% |
| Denmark | 1.80% |
| Switzerland | 1.49% |
| Australia | 1.41% |
| China | 1.05% |
| Japan | 0.84% |
| France | 0.71% |
| Israel | 0.46% |
| Other | 0.40% |
| Italy | 0.27% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- GrowthTechnology
- Inception Date
- Aug 24, 2022
- Exchange
- NYSE_ARCA
- Description
- The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Similar ETFs
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund issued by iShares that launched on Aug 24, 2022. It currently manages $5.7M in assets under management. The fund charges an expense ratio of 0.47%. The fund holds 69 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 45.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | DNTH | DIANTHUS THERAPEUTICS INC | 5.06% | 2,739 | $287K |
| 2 | PRAX | PRAXIS PRECISION MEDICINES INC | 4.93% | 868 | $280K |
| 3 | XENE | XENON PHARMACEUTICALS INC | 4.92% | 4,264 | $279K |
| 4 | ALKS | ALKERMES | 4.81% | 5,153 | $273K |
| 5 | ARWR | ARROWHEAD PHARMACEUTICALS INC | 4.61% | 3,016 | $262K |
| 6 | ACAD | ACADIA PHARMACEUTICALS INC | 4.35% | 9,949 | $247K |
| 7 | SRRK | SCHOLAR ROCK HOLDING CORP | 4.34% | 4,979 | $246K |
| 8 | PTCT | PTC THERAPEUTICS INC | 4.30% | 3,109 | $244K |
| 9 | NBIX | NEUROCRINE BIOSCIENCES INC | 4.13% | 1,345 | $234K |
| 10 | ARGX | ARGENX SE ADR | 4.04% | 248 | $229K |
| 11 | AXSM | AXSOME THERAPEUTICS INC | 4.04% | 949 | $229K |
| 12 | BIIB | BIOGEN INC | 3.99% | 1,129 | $226K |
| 13 | DNLI | DENALI THERAPEUTICS INC | 3.61% | 8,750 | $205K |
| 14 | DYN | DYNE THERAPEUTICS INC | 3.27% | 7,764 | $185K |
| 15 | EWTX | EDGEWISE THERAPEUTICS INC | 3.20% | 4,615 | $181K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.13% | |
| 1W | +1.73% | |
| 1M | -2.66% | |
| 3M | +9.81% | |
| 6M | +15.08% | |
| YTD | +18.58% | |
| 1Y | +64.22% | |
| 3Y | +54.67% | |
| 5Y | +53.42% |
Moving Averages
20-Day MA
$38.41
Below 20-Day MA50-Day MA
$36.46
Above 50-Day MA200-Day MA
$32.85
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$40.29
Current Price
$37.72
52-Week Low
$22.95
$22.95$40.29
Current Yield
1.00%
Annual Dividend
$0.7471
Frequency
Annualx/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | IBRN | Healthcare(212 ETFs) | Growth(409 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.47% | 0.62% | 0.65% |
| AUM | $5.7M | $1.86B | $3.03B |
| Dividend Yield | 1.00% | 3.66% | 5.84% |
| Avg Volume | 3.7K | 445.6K | 178.0K |
| Holdings | 69 | 147 | 78 |
| Performance | |||
| 1-Month Return | -1.42% | -0.85% | -1.71% |
| 6-Month Return | +21.58% | +12.94% | +8.23% |
| YTD Return | +16.62% | +9.31% | +5.58% |
| 1-Year Return | +34.74% | +14.67% | +5.11% |
Compare with Another ETF
Search for an ETF to compare with IBRN:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.